“…BACKGROUND: Hepatitis C virus (HCV) infection is a major worldwide health problem that can cause liver fibrosis and hepatocellular carcinoma (HCC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: To assess the effectiveness of Sofosbuvir (SOF) and Daclatasvir (DCV) in patients with chronic hepatitis C (CHC), compensated cirrhosis (CC) and decompensated cirrhosis (DCLD) either treatment naïve or experienced. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PURPOSE: To investigate long-term incidence of hepatocellular carcinoma (HCC) and the factors associated with HCC occurrence after achieving sustained virological response (SVR) by direct-acting antiviral agent (DAA) treatment for hepatitis C virus (HCV). METHODS: A total of 476 patients (male 227, female 249; median age 68) with chronic HCV infection who were treated with DAAs and achieved SVR were analyzed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: The World Health Organisation aim to eliminate hepatitis C (HCV) as a public health concern by 2030. …”
Enlace del recurso
Enlace del recurso

“…BACKGROUND & AIMS: Kazakhstan has implemented comprehensive programs to reduce the incidence of Hepatitis B and Hepatitis C. This study aims to assess seroprevalence and risk factors for HBsAg and anti-HCV positivity in three large regions of Kazakhstan. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Objective: Patients with chronic hepatitis C are subjected to a greater risk of cardiovascular disease and difficult to control diabetes mellitus type 2 (T2DM) comparatively to people that have never contracted Hepatitis C Virus (HCV). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) is curable, but incarcerated populations face barriers to treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The sustained virologic response and elimination of HCV is widely viewed as a true cure of chronic hepatitis C as it associates with amelioration of histological liver damage and improved clinical outcomes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…MAIN OUTCOMES AND MEASURES: Hepatitis C virus as indicated on the newborn’s birth certificate. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…IMPORTANCE: Initiation of injection drug use may be more frequent among people dispensed prescription opioid therapy for noncancer pain, potentially increasing the risk of hepatitis C virus (HCV) acquisition. OBJECTIVE: To assess the association between medically dispensed long-term prescription opioid therapy for noncancer pain and HCV seroconversion among individuals who were initially injection drug use–naive. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Difficult-to-treat populations with chronic hepatitis C (CHC), in the era of interferon treatment, included patients with liver cirrhosis, kidney impairment, treatment-experienced individuals, and those coinfected with the human immunodeficiency virus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: All newly diagnosed cases of hepatitis C reported between 2008 and 2018, in all regions of Brazil, were included. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND & AIMS: Development of a prophylactic hepatitis C virus (HCV) vaccine will require accurate and reproducible measurement of neutralizing breadth of vaccine-induced antibodies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) infections are emerging as one of the foremost challenges in healthcare owing to its chronicity and the virus’s quasispecies nature. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Objective To review the efficacy of the combination of pegylated interferon-α 2b and ribavirin, and sofosbuvir and ribavirin in achieving sustained viral response (SVR) in chronic hepatitis C genotypes 1 and 3 in children. Methods A retrospective descriptive study was performed for children under 15 years of age treated for chronic hepatitis C at Pakistan Kidney and Liver Institute and Research Centre, Lahore, between 2018 and 2019. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Hepatitis C virus (HCV) a major human pathogen infecting millions of individuals worldwide, thereby increasing the risks for chronic liver diseases and has been discovered that HIV/HCV co-infected patients have a greater risk. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Early diagnosis of hepatitis C virus (HCV) infection is essential for prompt initiation of treatment and prevention of transmission, yet several logistical barriers continue to limit access to HCV testing. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Hepatitis C virus (HCV) is an ongoing global public health threat affecting millions worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso